Why vaccines may work less well as we age: new study investigates
NCT ID NCT06128915
First seen Mar 05, 2026 · Last updated May 23, 2026 · Updated 11 times
Summary
This study explores why older adults often have weaker responses to the pneumonia vaccine. Researchers will compare immune cells called neutrophils in 60 healthy young (21-40) and older (65+) adults before and after receiving the Prevnar-13 vaccine. The goal is to understand age-related changes in immunity, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University at Buffalo
RECRUITINGBuffalo, New York, 14203, United States
Contact
Conditions
Explore the condition pages connected to this study.